Trichome

Content deleted Content added
CheMoBot (talk | contribs)
Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Wikipedia_talk:Wi
Pashihiko (talk | contribs)
No edit summary
Line 22: Line 22:
| ATCCode_prefix = R02
| ATCCode_prefix = R02
| ATCCode_suffix = AA01
| ATCCode_suffix = AA01
| KEGG = D07376
}}
}}
|Section2= {{Chembox Properties
|Section2= {{Chembox Properties

Revision as of 02:45, 8 December 2010

Ambazone[1]
Names
IUPAC name
[4-(2-(Diaminomethylidene)hydrazinyl)phenyl]iminothiourea
Other names
2-[4-[(aminoiminomethyl)hydrazono]-2,5-cyclohexadien-1-ylidene]-Hydrazinecarbothioamide; (4-Oxo-2,5-cyclohexadien-1-ylideneamino)guanidine thiosemicarbazone; 1,4-Benzoquinone amidinohydrazone thiosemicarbazone; Ambazon; Anginon; Benzoquinone guanylhydrazone thiosemicarbazone; Faringosept; Guanothiazon; Inversal; Inversal; Ivertol; N-Guanidino-N'-thioureido-p-benzoquinonediimide; Primal; p-Benzoquinone amidinohydrazone thiosemicarbazone;Faringosept (TN); Ambazone (INN); OAMBAZONE; Ambazonum [INN-Latin]; Ambazona [INN-Spanish]; Ambazone [INN:BAN:DCF]; CCRIS 1926; MLS001240207
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.007.922 Edit this at Wikidata
EC Number
  • 208-713-0
KEGG
  • InChI=1S/C8H11N7S/c9-7(10)14-12-5-1-3-6(4-2-5)13-15-8(11)16/h1-4H,(H4,9,10,14)(H3,11,15,16)/b12-5-,13-6+ checkY
    Key: MLMFUKWWZIZRHX-UWRPRBHNSA-N checkY
  • InChI=1/C8H11N7S/c9-7(10)14-12-5-1-3-6(4-2-5)13-15-8(11)16/h1-4H,(H4,9,10,14)(H3,11,15,16)/b12-5-,13-6+
    Key: MLMFUKWWZIZRHX-UWRPRBHNBF
  • NC(=S)N\N=C1\C=C/C(=N\NC(N)=N)/C=C1
Properties
C8H11N7S
Molar mass 237.28 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Ambazone is an oral antiseptic.

Applications

Bacteriostatic action on hemolytic streptococcus, streptococcus pneumoniae and viridans streptococcus.

References


Leave a Reply